Reorganizing the Global Pharmacovigilance Function

March 4, 2020 Summer Foote

An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of different resourcing scenarios, the group’s head turned to BTG. We delivered an independent pharmacovigilance organization specialist and former engagement lead in Accenture’s life science practice. She worked with internal executives to evaluate the most efficient model, then develop detailed organization-wide communication and implementation plans.

Previous Flipbook
On-Demand Talent for Biopharma
On-Demand Talent for Biopharma

Get on-demand talent to help you fuel your critical initiatives, pivot faster, and cover any skills or capa...

Next Flipbook
BTG Key Strengths: Clinical Solutions
BTG Key Strengths: Clinical Solutions

Getting new drugs through trials is expensive—and ever more complex, with a myriad of competing issues to m...

Get our free guide to working with on-demand talent.

Read Now